Cart

No products

Shipping $0.00
Total $0.00

Cart Check out

CGA PS-49

CGA PS-49 CGA Position Statement on Appropriate and Effective Regulations for Medical Gases within 21 CFR Parts 201, 205, and 210/211

en, Position Statement by Compressed Gas Association, 08/01/2014

More details

Download

PDF AVAILABLE FORMATS IMMEDIATE DOWNLOAD
$7.20

$16.00

(price reduced by 55 %)

Full Description

This position statement reflects the Compressed Gas Association's (CGA) consensus position for how the FDA's regulations for finished pharmaceuticals found in Title 21 of the U.S. Code of Federal Regulations (21 CFR) Parts 201 (labeling), 205 (wholesale distribution), and 210 and 211 (GMPs), should be revised for designated medical gases or combinations thereof. This position is consistent with established and long standing industry practice yielding safe and efficacious designated medical gases and consistent with the Congressional intent in the FDASIA identifying the need for revisions to 21 CFR.

Contact us